UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status

CNS drugs, 2016-12, Vol.30 (12), p.1127-1135

2016

Volltextzugriff (PDF)

Altered Gut Microbiota in a Fragile X Syndrome Mouse Model

Frontiers in neuroscience, 2021-05, Vol.15, p.653120-653120

2021

Volltextzugriff (PDF)

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

Scientific reports, 2020-10, Vol.10 (1), p.18058-18058, Article 18058

2020

Volltextzugriff (PDF)

Fragile X and Related Autism Spectrum Disorders

Hurley, Michel J

2023

Volltextzugriff (PDF)

Neuroprotective role for RORA in Parkinson's disease revealed by analysis of post-mortem brain and a dopaminergic cell line

NPJ Parkinson's Disease, 2023-07, Vol.9 (1), p.119-119, Article 119

2023

Volltextzugriff (PDF)

Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer’s disease

iScience, 2024-08, Vol.27 (8), p.110348, Article 110348

2024

Volltextzugriff (PDF)

Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers

Human mutation, 2003-07, Vol.22 (1), p.79-85

2003

Volltextzugriff (PDF)

Genome Sequencing Variations in the Octodon degus , an Unconventional Natural Model of Aging and Alzheimer's Disease

Frontiers in aging neuroscience, 2022-06, Vol.14, p.894994-894994

2022

Volltextzugriff (PDF)

Bile acids and neurological disease

Pharmacology & therapeutics (Oxford), 2022-12, Vol.240, p.108311-108311, Article 108311

2022

Volltextzugriff (PDF)

Many Paths to Alzheimer’s Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors

Journal of Alzheimer's disease, 2023-01, Vol.95 (4), p.1371-1382

2023

Volltextzugriff (PDF)

Controlling the misuse of cobalt in horses

Drug testing and analysis, 2015-01, Vol.7 (1), p.21-30

2015

Volltextzugriff (PDF)

Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice

Brain (London, England : 1878), 2022-03, Vol.145 (1), p.76-82

2022

Volltextzugriff (PDF)

Design considerations and effects of LNA in PCR primers

Molecular and cellular probes, 2003-10, Vol.17 (5), p.253-259

2003

Volltextzugriff (PDF)

The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases

Pharmacology & therapeutics (Oxford), 2018-08, Vol.188, p.36-44

2018

Volltextzugriff (PDF)

Voltage-gated calcium channels and Parkinson's disease

Pharmacology & therapeutics (Oxford), 2012-03, Vol.133 (3), p.324-333

2012

Volltextzugriff (PDF)

Preface. Omic Studies of Neurodegenerative Disease: Part A

International review of neurobiology, 2015, Vol.121, p.xi

Hurley, Michael J

2015

Volltextzugriff (PDF)

NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome

Neuromolecular medicine, 2015-03, Vol.17 (1), p.71-82

2015

Volltextzugriff (PDF)

Sampling almonds for aflatoxin, part I: estimation of uncertainty associated with sampling, sample preparation, and analysis

Journal of AOAC International, 2006-07, Vol.89 (4), p.1027-1034

2006

Volltextzugriff (PDF)

α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study

Brain communications, 2023-11, Vol.5 (6), p.fcad285-fcad285

2023

Volltextzugriff (PDF)

Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization

Journal of molecular neuroscience, 2015-03, Vol.55 (3), p.715-724

2015

Volltextzugriff (PDF)

Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson’s Disease

Journal of molecular neuroscience, 2015-09, Vol.57 (1), p.48-62

2015

Volltextzugriff (PDF)

Parkinson's disease is associated with altered expression of Cav1 channels and calcium-binding proteins

Brain (London, England : 1878), 2013-07, Vol.136 (Pt 7), p.2077-2097

2013

Volltextzugriff (PDF)

Proteomic Analysis of Striatum from MPTP-Treated Marmosets (Callithrix jacchus) with l-DOPA-Induced Dyskinesia of Differing Severity

Journal of molecular neuroscience, 2014-02, Vol.52 (2), p.302-312

2014

Volltextzugriff (PDF)

Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease

Frontiers in aging neuroscience, 2017-03, Vol.9, p.64

2017

Volltextzugriff (PDF)

Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR

The European journal of neuroscience, 2003-11, Vol.18 (9), p.2668-2672

2003

Volltextzugriff (PDF)

1 – 25 von 1.036

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(917)
Mit Volltextzugriff
(868)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.032)
Japanisch
(112)
Portugiesisch
(2)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status

Altered Gut Microbiota in a Fragile X Syndrome Mouse Model

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

Fragile X and Related Autism Spectrum Disorders

Neuroprotective role for RORA in Parkinson's disease revealed by analysis of post-mortem brain and a dopaminergic cell line

Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer’s disease

Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers

Genome Sequencing Variations in the Octodon degus , an Unconventional Natural Model of Aging and Alzheimer's Disease

Bile acids and neurological disease

Many Paths to Alzheimer’s Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors

Controlling the misuse of cobalt in horses

Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice

Design considerations and effects of LNA in PCR primers

The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases

Voltage-gated calcium channels and Parkinson's disease

Preface. Omic Studies of Neurodegenerative Disease: Part A

NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome

Sampling almonds for aflatoxin, part I: estimation of uncertainty associated with sampling, sample preparation, and analysis

α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study

Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization

Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson’s Disease

Parkinson's disease is associated with altered expression of Cav1 channels and calcium-binding proteins

Proteomic Analysis of Striatum from MPTP-Treated Marmosets (Callithrix jacchus) with l-DOPA-Induced Dyskinesia of Differing Severity

Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease

Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR

Suchergebnisse filtern